List of API Suppliers of Oteracil Potassium API listed on PharmaCompass.com

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 2207-75-2, Oteracil potassium, Oxonic acid potassium salt, Allantoxanic acid potassium salt, Potassium azaorotate, Oxonic acid, potassium salt
Molecular Formula
C4H2KN3O4
Molecular Weight
195.17  g/mol
InChI Key
IAPCTXZQXAVYNG-UHFFFAOYSA-M
FDA UNII
4R7FFA00RX

Oteracil Potassium
Oteracil Potassium is the potassium salt of oxonate, an enzyme inhibitor that modulates 5- fluorouracil (5-FU) toxicity. Potassium oxonate inhibits orotate phosphoribosyltransferase, which catalyzes the conversion of 5-FU to its active or phosphorylated form, FUMP. Upon oral administration, Oxonate is selectively distributed to the intracellular sites of tissues lining the small intestines, producing localized inhibitory effects within the gastrointestinal tract. As a result, 5-FU associated gastrointestinal toxic effects are reduced and the incidence of diarrhea or mucositis is decreased in 5-FU related therapy.
1 2D Structure

Oteracil Potassium

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
potassium;4,6-dioxo-1H-1,3,5-triazine-2-carboxylate
2.1.2 InChI
InChI=1S/C4H3N3O4.K/c8-2(9)1-5-3(10)7-4(11)6-1;/h(H,8,9)(H2,5,6,7,10,11);/q;+1/p-1
2.1.3 InChI Key
IAPCTXZQXAVYNG-UHFFFAOYSA-M
2.1.4 Canonical SMILES
C1(=NC(=O)NC(=O)N1)C(=O)[O-].[K+]
2.2 Other Identifiers
2.2.1 UNII
4R7FFA00RX
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 2207-75-2

2. Oteracil Potassium

3. Oxonic Acid Potassium Salt

4. Allantoxanic Acid Potassium Salt

5. Potassium Azaorotate

6. Oxonic Acid, Potassium Salt

7. Potassium 4,6-dioxo-1,4,5,6-tetrahydro-1,3,5-triazine-2-carboxylate

8. Oxonate

9. Potassium 2,6-dihydroxytriazinecarboxylate

10. Potassium 4,6-dihydroxy-1,3,5-triazine-2-carboxylate

11. Oxonate, Potassium

12. 4r7ffa00rx

13. Oxonic Acid (potassium Salt)

14. Chebi:80230

15. Mfcd00010565

16. Allantoxanic Acid, Potassium Salt

17. Allantoxanic Acid, Monopotassium Salt

18. Potassiumoxonate

19. Nsc28841

20. Nsc-28841

21. Potassium Allantoxanate

22. Ncgc00166236-01

23. 5-azaoroticacid,potassiumsalt

24. Potassium Otastat

25. 5-azaorotic Acid, Potassium Salt

26. Potassium 1,4,5,6-tetrahydro-4,6-dioxo-1,3,5-triazine-2-carboxylate

27. Einecs 218-627-5

28. Nsc 28841

29. Potassium 4,6-dioxo-1h-1,3,5-triazine-2-carboxylate

30. Potassium S-triazine-2,4-dione-6-carboxylate

31. Unii-4r7ffa00rx

32. Dsstox_cid_26568

33. Dsstox_rid_81727

34. Dsstox_gsid_46568

35. Kox

36. Schembl339417

37. Oteracil Potassium[jan]

38. Chembl3184847

39. Dtxsid5046568

40. Oteracil Potassium [jan]

41. Act04739

42. Amy40569

43. Bcp06172

44. Oteracil Potassium [who-dd]

45. Tox21_112362

46. 1,4,5,6-tetrahydro-4,6-dioxo-s-triazine-2-carboxylic Acid, Potassium Salt

47. Akos006229816

48. Akos015961942

49. Akos015964230

50. Akos025116606

51. Ac-2039

52. 1,3,5-triazine-2-carboxylic Acid, 1,4,5,6-tetrahydro-4,6-dioxo-, Monopotassium Salt

53. S-1 Component Oteracil Potassium

54. As-13301

55. Hy-17511

56. Sy036250

57. Cas-2207-75-2

58. Teysuno Component Oteracil Potassium

59. Db-010118

60. Ft-0603597

61. O0164

62. Oteracil Potassium Component Of Teysuno

63. F14898

64. Q-100280

65. Q27149343

66. Potassium;4,6-dioxo-1h-1,3,5-triazine-2-carboxylate

2.4 Create Date
2005-07-19
3 Chemical and Physical Properties
Molecular Weight 195.17 g/mol
Molecular Formula C4H2KN3O4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count1
Exact Mass194.96823704 g/mol
Monoisotopic Mass194.96823704 g/mol
Topological Polar Surface Area111 Ų
Heavy Atom Count12
Formal Charge0
Complexity274
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

ABOUT THIS PAGE

Oteracil Potassium Manufacturers | Traders | Suppliers

Oteracil Potassium Manufacturers, Traders, Suppliers 1
80

We have 6 companies offering Oteracil Potassium

Get in contact with the supplier of your choice:

  1. Formosa Laboratories
  2. Green Stone Swiss Co ., Ltd
  3. Kyongbo Pharmaceutical Co., Ltd
  4. Lunan Pharmaceutical
  5. Shiratori Pharmaceutical
  6. Sumitomo Chemical
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty